Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Humana Throws the First Pitch Event to Connect Minority-Owned Businesses to Top Humana Suppliers: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Throws the First Pitch Event to Connect Minority-Owned Businesses to Top Humana Suppliers


The Supplier Diversity Team of Humana Inc. (NYSE: HUM) hosted the First Pitch, a virtual forum where participants from the Humana Mentor Protégé Program had the opportunity to pitch their business

NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Highlights Spatial Biology Research at the 2022 American Association of Cancer Research (AACR) Conference


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of over 125 studies enabled by

Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022:
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022


Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting

Quidel Announces Preliminary Revenue for First Quarter 2022
Quidel Announces Preliminary Revenue for First Quarter 2022


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects

Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27:
Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the close of trading on the

Dexcom Publishes Annual Sustainability Report: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Publishes Annual Sustainability Report


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its third annual Sustainability Report. This report

Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second

AMN Healthcare to Hold First Quarter 2022 Earnings Conference Call on Thursday, May 5, 2022: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare to Hold First Quarter 2022 Earnings Conference Call on Thursday, May 5, 2022


AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call to discuss its first quarter 2022 financial results and second quarter 2022 outlook on Thursday, May 5, 2022 at 5:00 p.m

Premier, Inc. to Report Fiscal 2022 Third-Quarter Results and Host Conference Call on May 3, 2022: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. to Report Fiscal 2022 Third-Quarter Results and Host Conference Call on May 3, 2022


Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2022 third quarter on Tuesday, May 3, 2022, at approximately 6:30 a.m. ET. The company will also

Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC):
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)


Agilent Technologies Inc. (NYSE: A) today announced CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx immunohistochemical assay to extend the use of the test to patients diagnosed

Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma:
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma


Agilent Technologies Inc. (NYSE: A) today announced it has expanded CE-IVD marking in the European Union for its PD-L1 IHC 28-8 pharmDx as an aid in identifying esophageal squamous cell carcinoma

Agilent Joins AMBIC to Advance Biomanufacturing:
Agilent Joins AMBIC to Advance Biomanufacturing


Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC). Joining AMBIC demonstrates the company’s

Acadia Healthcare Announces Christopher Hunter as New Chief Executive Officer: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Announces Christopher Hunter as New Chief Executive Officer


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that its Board of Directors has named Christopher Hunter as the Company’s new Chief Executive Officer. He will join Acadia on April

Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2022 financial results after market close on Thursday, April 28, 2022. Management will hold a conference call

Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, continued its $5.5 million investment in six communities across the United States to improve greater

Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II

Dexcom Announces Four-for-One Forward Stock Split: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Four-for-One Forward Stock Split


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today that its Board of Directors has approved a four-for-one

Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual

Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the second quarter of fiscal year 2022, the period ended February 28, 2022, after the close of the

AMN Healthcare Named to Barron’s 100 Most Sustainable Companies: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Named to Barron’s 100 Most Sustainable Companies


AMN Healthcare, the nation’s leader in total talent solutions for healthcare organizations, has been named to America’s 100 Most Sustainable Companies by Barron’s magazine.



“The AMN team and our

Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders


Simulations Plus (Nasdaq: SLP) is celebrating 25 years in business and continuing the commitment to improve public health through innovative solutions with a $25,000 donation to the National

Southcoast Behavioral Health Expands Services and Capacity: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Southcoast Behavioral Health Expands Services and Capacity


Southcoast Behavioral Health today reinforced its strong commitment to the communities it serves through the addition of a dedicated child and adolescent behavioral health program, expanding the

Premier Inc. Named One of the 2022 World’s Most Ethical Companies® by Ethisphere® for 15th Consecutive Year: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. Named One of the 2022 World’s Most Ethical Companies® by Ethisphere® for 15th Consecutive Year


Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been recognized by Ethisphere®, a global leader in defining and advancing the standards of ethical

AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year


AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Susan Salka, its President and Chief Executive

Simulations Plus Releases MembranePlus 3.0: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases MembranePlus 3.0


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced it has